Tvardi Therapeutics TVRD
NASDAQ TVRD
$0.99 +0.02 (+2.27%)
At close: Oct 20, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) EV to EBITDA (2020 - 2021)

Updated

Tvardi Therapeutics' (TVRD) EV to EBITDA came in at 27.46 for Q3 2021, down 65.3% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) EV to EBITDA (2020 - 2021) Analysis & Trends

For the trailing twelve months through Sep 30, 2021, EV to EBITDA at Tvardi Therapeutics was 5.37; for FY2020, it came in at 102.54.

  • According to Business Quant data, EV to EBITDA for the three prior quarters was 79.14 (Q2 2021), 75.89 (Q1 2021) and 102.54 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Tvardi Therapeutics 9.71 Mn -98.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 27.46
Jun 30, 2021 79.14
Mar 31, 2021 75.89
Dec 31, 2020 102.54
API Access

Tvardi Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=TVRD&period=max&api_key=YOUR_API_KEY